Andrea Mattarei Selected Research

N-Methyl-D-Aspartate Receptors (NMDA Receptors)

10/2023	Esmethadone-HCl (REL-1017): a promising rapid antidepressant.
10/2022	Esmethadone (REL-1017) and Other Uncompetitive NMDAR Channel Blockers May Improve Mood Disorders via Modulation of Synaptic Kinase-Mediated Signaling.
1/2022	REL-1017 (Esmethadone) as Adjunctive Treatment in Patients With Major Depressive Disorder: A Phase 2a Randomized Double-Blind Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea Mattarei Research Topics

Disease

13	Neoplasms (Cancer) 05/2023 - 01/2017
6	Major Depressive Disorder (Major Depressive Disorders) 05/2024 - 01/2022
2	Pathologic Processes 01/2023 - 01/2019
2	Neoplasm Metastasis (Metastasis) 12/2022 - 01/2019
2	Adenocarcinoma 05/2022 - 01/2017
2	Tetanus 11/2021 - 01/2017
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2021
2	Melanoma (Melanoma, Malignant) 01/2021 - 10/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2024
1	COVID-19 12/2023
1	Dementia (Dementias) 10/2023
1	X-Linked Bulbo-Spinal Atrophy 01/2023
1	Mood Disorders (Mood Disorder) 10/2022
1	Multiple Myeloma 04/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2022
1	Leukemia 02/2022
1	Autoimmune Hepatitis 01/2022
1	Disease Progression 01/2022
1	Muscle Spasticity (Spastic) 11/2021
1	Paralysis (Palsy) 01/2020
1	Bites and Stings (Sting) 01/2020
1	Snake Bites (Snake Bite) 01/2020
1	Inflammation (Inflammations) 01/2019
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Obesity 07/2017
1	Insulin Resistance 07/2017
1	Glioma (Gliomas) 01/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2017
1	Botulism 12/2015

Drug/Important Bio-Agent (IBA)

6	Potassium Channels (Potassium Channel)IBA 12/2022 - 01/2017
5	Antidepressive Agents (Antidepressants)IBA 05/2024 - 01/2022
5	Proteins (Proteins, Gene)FDA Link 01/2024 - 11/2021
4	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2022 - 01/2017
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2023 - 01/2022
3	Liposomes (Liposome)IBA 01/2021 - 05/2018
2	AvidinIBA 12/2023 - 01/2022
2	Nucleic AcidsIBA 12/2023 - 01/2022
2	Phosphotransferases (Kinase)IBA 10/2022 - 10/2017
2	Kv1.3 Potassium ChannelIBA 04/2022 - 01/2017
2	Glycerol (Glycerine)FDA LinkGeneric 01/2021 - 07/2017
1	Peptides (Polypeptides)IBA 05/2023
1	polyglutamineIBA 01/2023
1	AndrogensIBA 01/2023
1	Androgen Receptors (Androgen Receptor)IBA 01/2023
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 12/2022
1	CalciumIBA 12/2022
1	Gemcitabine FDA Link 05/2022
1	Albumin-Bound Paclitaxel FDA Link 05/2022
1	venetoclaxIBA 04/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Formaldehyde (Formol)FDA Link 11/2021
1	Immunoglobulins (Immunoglobulin)IBA 11/2021
1	tetanospasmin (tentoxilysin)IBA 11/2021
1	ExotoxinsIBA 11/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	1-dodecylpyridoxal (PLD)IBA 01/2021
1	flopropioneIBA 01/2021
1	NUCC-390IBA 01/2020
1	taipoxinIBA 01/2020
1	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2020
1	VenomsIBA 01/2020
1	LigandsIBA 01/2019
1	PorinsIBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019
1	Voltage-Dependent Anion ChannelsIBA 01/2019
1	CateninsIBA 01/2019
1	Arginine (L-Arginine)FDA Link 05/2018
1	Furocoumarins (Furanocoumarins)IBA 01/2018
1	QuercetinIBA 10/2017
1	Ion Channels (Ion Channel)IBA 10/2017
1	AdipokinesIBA 07/2017
1	pterostilbeneIBA 07/2017
1	CarbamatesIBA 07/2017
1	Triglycerides (Triacylglycerol)IBA 07/2017
1	NeurotoxinsIBA 01/2017
1	5-(4-phenylbutoxy)psoralenIBA 01/2017
1	Clofazimine (Lamprene)FDA Link 01/2017
1	incobotulinumtoxinA FDA Link 12/2015

Therapy/Procedure

3	Therapeutics 04/2022 - 11/2021
1	Castration 01/2023